Saba Manshaei
Max Planck Institute of Experimental Medicine(DE)
Publications by Year
Research Areas
Pituitary Gland Disorders and Treatments, Single-cell and spatial transcriptomics, Cancer, Hypoxia, and Metabolism, Congenital heart defects research, Hedgehog Signaling Pathway Studies
Most-Cited Works
- → Cardiac glycosides are broad-spectrum senolytics(2019)340 cited
- → Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer(2023)211 cited
- → Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target(2018)207 cited
- → MAPK pathway activation in the embryonic pituitary results in stem cell compartment expansion, differentiation defects and provides insights into the pathogenesis of papillary craniopharyngioma(2017)79 cited
- → Stem/progenitor cells in pituitary organ homeostasis and tumourigenesis(2017)37 cited
- → BRF1-mediated paracrine signalling from pituitary stem cells is required for terminal differentiation of pituitary committed progenitors(2022)
- → RF13 | PMON143 BRF1-Mediated Paracrine Signalling by a Subset of SOX2-Expressing Stem Cells is Required for Normal Development of the Stem Cell Compartment and Terminal Differentiation of Pituitary Committed Progenitors(2022)
- → CP-03. EXTRACELLULAR MATRIX REMODELING REVEALS NON-CELL AUTONOMOUS TUMOR FORMATION MECHANISM IN ADAMANTINOMATOUS CRANIOPHARYNGIOMAS(2024)
- → Paracrine Signalling From SOX2-Expressing Pituitary Embryonic Cells Is Required for Terminal Differentiation of Hormone-Producing Cells(2021)
- → BRF1-Mediated Paracrine Signalling by a Subset of SOX2-Expressing Stem Cells is required for Normal Development of the Stem Cell Compartment and Terminal Differentiation of Pituitary Committed Progenitors(2023)